335 related articles for article (PubMed ID: 29052524)
1. Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet's disease.
Perazzio SF; Soeiro-Pereira PV; Dos Santos VC; de Brito MV; Salu B; Oliva MLV; Stevens AM; de Souza AWS; Ochs HD; Torgerson TR; Condino-Neto A; Andrade LEC
Arthritis Res Ther; 2017 Oct; 19(1):235. PubMed ID: 29052524
[TBL] [Abstract][Full Text] [Related]
2. Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations.
Perazzio SF; Soeiro-Pereira PV; de Souza AW; Condino-Neto A; Andrade LE
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S85-95. PubMed ID: 26394190
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD40 ligand stimulates CD40-dependent activation of the β2 integrin Mac-1 and protein kinase C zeda (PKCζ) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst.
Jin R; Yu S; Song Z; Zhu X; Wang C; Yan J; Wu F; Nanda A; Granger DN; Li G
PLoS One; 2013; 8(6):e64631. PubMed ID: 23785403
[TBL] [Abstract][Full Text] [Related]
4. Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients.
Fernández Bello I; Álvarez MT; López-Longo FJ; Arias-Salgado EG; Martín M; Jiménez-Yuste V; Rodríguez de la Rúa A; Butta NV
Thromb Haemost; 2012 Jan; 107(1):88-98. PubMed ID: 22116092
[TBL] [Abstract][Full Text] [Related]
5. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients.
Danese S; Katz JA; Saibeni S; Papa A; Gasbarrini A; Vecchi M; Fiocchi C
Gut; 2003 Oct; 52(10):1435-41. PubMed ID: 12970136
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil activation in Behçet's disease.
Eksioglu-Demiralp E; Direskeneli H; Kibaroglu A; Yavuz S; Ergun T; Akoglu T
Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S19-24. PubMed ID: 11760393
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil CD40 enhances platelet-mediated inflammation.
Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
[TBL] [Abstract][Full Text] [Related]
8. The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin.
Natal C; Restituto P; Iñigo C; Colina I; Díez J; Varo N
J Clin Endocrinol Metab; 2008 Jun; 93(6):2319-27. PubMed ID: 18349065
[TBL] [Abstract][Full Text] [Related]
9. Activation of neutrophils by testosterone in Behçet's disease.
Yavuz S; Ozilhan G; Elbir Y; Tolunay A; Eksioglu-Demiralp E; Direskeneli H
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S46-51. PubMed ID: 17949551
[TBL] [Abstract][Full Text] [Related]
10. Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in Behçet's disease.
Safi R; Kallas R; Bardawil T; Mehanna CJ; Abbas O; Hamam R; Uthman I; Kibbi AG; Nassar D
J Dermatol Sci; 2018 Nov; 92(2):143-150. PubMed ID: 30237006
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic proline-rich polypeptide is a regulator of oxidative burst in human neutrophils and monocytes.
Davtyan TK; Manukyan HA; Mkrtchyan NR; Avetisyan SA; Galoyan AA
Neuroimmunomodulation; 2005; 12(5):270-84. PubMed ID: 16166806
[TBL] [Abstract][Full Text] [Related]
12. CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.
Li G; Sanders JM; Bevard MH; Sun Z; Chumley JW; Galkina EV; Ley K; Sarembock IJ
Am J Pathol; 2008 Apr; 172(4):1141-52. PubMed ID: 18349125
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention.
Choudhury A; Chung I; Panja N; Patel J; Lip GYH
Chest; 2008 Sep; 134(3):574-581. PubMed ID: 18641098
[TBL] [Abstract][Full Text] [Related]
14. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
Lee SP; Ataga KI; Orringer EP; Phillips DR; Parise LV
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1626-31. PubMed ID: 16601237
[TBL] [Abstract][Full Text] [Related]
15. Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products.
Varo N; Libby P; Nuzzo R; Italiano J; Doria A; Schönbeck U
Diab Vasc Dis Res; 2005 May; 2(2):81-7. PubMed ID: 16308911
[TBL] [Abstract][Full Text] [Related]
16. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil Extracellular Traps Promote Aberrant Macrophages Activation in Behçet's Disease.
Li L; Yu X; Liu J; Wang Z; Li C; Shi J; Sun L; Liu Y; Zhang F; Chen H; Zheng W
Front Immunol; 2020; 11():590622. PubMed ID: 33633724
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases.
Ludwiczek O; Kaser A; Tilg H
Int J Colorectal Dis; 2003 Mar; 18(2):142-7. PubMed ID: 12548417
[TBL] [Abstract][Full Text] [Related]
19. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.
Macey M; Hagi-Pavli E; Stewart J; Wallace GR; Stanford M; Shirlaw P; Fortune F
Rheumatology (Oxford); 2011 Oct; 50(10):1849-59. PubMed ID: 21719422
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.
Neves FS; Carrasco S; Goldenstein-Schainberg C; Gonçalves CR; de Mello SB
Clin Rheumatol; 2009 Dec; 28(12):1403-10. PubMed ID: 19701803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
